MSOSAdvisorShares Pure US Cannabis ETF
Seeks long-term capital appreciation.
By AdvisorShares · Launched 2020
Annual Cost
0.78%
#4,241 of 6,040 · expensive
Fund Size
$974M
#1,198 of 6,040 · large
Return (1Y)
+12.5%
Track Record
6 years
#2,144 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$10,877+8.8%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 24.8% of funddiversified
Curaleaf Holdings Inc
8.9%
BLACKROCK TREASURY TRUST
7.0%
TerrAscend Corp.
3.6%
Village Farms Inte
1.5%
CANTOR FITZGERALD & CO.
0.9%
NOMURA INTERNATIONAL PLC
0.7%
CANTOR FITZGERALD & CO.
0.7%
NOMURA INTERNATIONAL PLC
0.5%
CANTOR FITZGERALD & CO.
0.5%
SNDL Inc
0.5%
Asset allocation
Cash
58.2%
Stocks
32.0%
Other
9.8%
By sector
Real Estate
50.2%
Industrials
29.6%
Consumer Cyclical
17.8%
Healthcare
2.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
103.1%High
Year-on-year price swings
Max drawdown
-96.2%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.17Below average
Sortino (3Y)
0.27Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in mid- and small-cap U.S. companies deriving at least 50% of revenue from the marijuana and hemp business. Concentrates at least 25% in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector.
- Inception date
- September 1, 2020
- Fund family
- AdvisorShares
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save MSOS to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18